7,170 Intuitive Surgical, Inc. $ISRG Shares Acquired by Defender Capital LLC.

Defender Capital LLC. grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 75.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 16,640 shares of the medical equipment provider’s stock after buying an additional 7,170 shares during the quarter. Intuitive Surgical makes up approximately 2.1% of Defender Capital LLC.’s portfolio, making the stock its 13th biggest position. Defender Capital LLC.’s holdings in Intuitive Surgical were worth $6,766,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in ISRG. Bank of New York Mellon Corp bought a new stake in shares of Intuitive Surgical during the 2nd quarter worth $1,335,753,000. J. Stern & Co. LLP grew its position in Intuitive Surgical by 18,504.6% in the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock worth $1,204,788,000 after acquiring an additional 2,115,814 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its stake in Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after acquiring an additional 1,027,475 shares during the last quarter. Polen Capital Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at about $477,225,000. Finally, Invesco Ltd. raised its position in Intuitive Surgical by 17.4% during the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock valued at $2,338,350,000 after purchasing an additional 611,268 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on ISRG. Raymond James Financial reaffirmed an “outperform” rating and set a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Citigroup reduced their price objective on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. Leerink Partners decreased their price objective on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a report on Friday, July 17th. Robert W. Baird dropped their target price on Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. Finally, Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Sunday, September 20th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $508.68.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $5.39 during trading on Thursday, hitting $401.24. 1,510,983 shares of the company’s stock traded hands, compared to its average volume of 2,437,212. The stock has a fifty day moving average of $378.15 and a two-hundred day moving average of $414.26. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The firm has a market cap of $141.75 billion, a P/E ratio of 45.96, a PEG ratio of 3.11 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period last year, the firm earned $1.81 earnings per share. As a group, analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 1,089 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $374.44, for a total value of $407,765.16. Following the transaction, the vice president directly owned 1,026 shares of the company’s stock, valued at $384,175.44. The trade was a 51.49% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy Ladd sold 72 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total value of $28,303.20. Following the completion of the sale, the director owned 179 shares of the company’s stock, valued at $70,364.90. The trade was a 28.69% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock worth $4,891,989 over the last three months. Corporate insiders own 0.60% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.